Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Inherited Retinal Disease Market from 2024 to 2025?

The market size for inherited retinal diseases has seen significant growth over the last few years. The projection shows an increase from $11.56 billion in 2024 to $12.58 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. The expansion experienced during the historic period can be credited to factors such as the embrace of gene therapy, regulatory encouragements, the growth of patient registries, an increase in clinical trials, and the rise of patient-focused solutions.

What Is the Projected Market Size of the Inherited Retinal Disease Market?

In the coming years, the market size of inherited retinal diseases is projected to witness substantial growth, anticipated to reach a whopping $17.42 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 8.5%. This surge during the prognosis tenure could be ascribed to factors such as a growing reliance on CRISPR, the advent of custom treatments, the emphasis on regenerative medicine, an increase in patient advocacy and the commitment to enhancing patients’ quality of life. Eye-catching trends in the forecast span include the advancement in optogenetics technology, the creation of new artificial retina implants, the broadening of digital health platform usage, the incorporation of artificial intelligence into disease modeling, and its application in formulating treatment plans.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

Who are the Major Competitors in the Inherited Retinal Disease Market Outlook?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

What Is Fueling Growth in the Inherited Retinal Disease Market?

The rising occurrence of macular degeneration is anticipated to drive the expansion of the inherited retinal disease market. This age-related eye disease damages the macula, leading to loss of central vision and difficulty with tasks like reading or recognizing people. Factors such as aging, increased life expectancy, and habits like smoking and poor nutrition that heighten the risk contribute to this growing prevalence. Treatment options for inherited retinal diseases can assist those struggling with macular degeneration by addressing the genetic root causes of retinal degeneration. These treatments slow down the progression of the disease, restore lost vision, or can even stop further damage to the retina. Consequently, they enhance visual outcomes and life quality for people grappling with age-related or genetically acquired macular degeneration. As a specific example, the Canadian Ophthalmological Society, a non-profit organization based in Canada, revealed in February 2024 that 2.5 million Canadians over the age of 55 lost their sight due to age-related macular degeneration (AMD). Hence, the climbing occurrence of macular degeneration fosters the growth of the inherited retinal disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp

Which Inherited Retinal Disease Market Segments Are Growing the Fastest?

The inherited retinal disease market covered in this report is segmented –

1) By Type: Diagnosis, Therapy

2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases

3) By Distribution Channel: Retail Sales, Direct Tender

4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users

Subsegments,

1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy

Which Industry Trends Are Shaping the Future of the Inherited Retinal Disease Market?

Major firms in the inherited retinal diseases market are focused on creating cutting-edge therapies like mutation-agnostic gene therapy, with the aim of expanding treatment options and covering a wider array of genetic variations linked to these diseases. With mutation-agnostic gene therapy, the focus is on larger genetic mechanisms or pathways instead of specific mutations, making it useful for a variety of genetic disorders. Nanoscope Therapeutics Inc, a biotech firm based in the U.S., reported positive clinical trial outcomes for its primary program, MCO-010, in March 2024. This program demonstrated improvements in vision for patients suffering from significant and permanent vision loss due to advanced retinitis pigmentosa. MCO-010 reached its primary and key secondary endpoints with meaningful statistical significance and without any severe adverse events.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Which Countries Are Leading the Inherited Retinal Disease Market?

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20850

This Report Delivers Insight On:

1. How big is the inherited retinal disease market, and how is it changing globally?

2. Who are the major companies in the inherited retinal disease market, and how are they performing?

3. What are the key opportunities and risks in the inherited retinal disease market right now?

4. Which products or customer segments are growing the most in the inherited retinal disease market?

5. What factors are helping or slowing down the growth of the inherited retinal disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model